97 related articles for article (PubMed ID: 38433226)
1. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.
Chen Y; Xie Y; Ci H; Cheng Z; Kuang Y; Li S; Wang G; Qi Y; Tang J; Liu D; Li W; Yang Y
BMC Med; 2024 Mar; 22(1):90. PubMed ID: 38433226
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis.
Zhong H; Liu S; Zhu J; Xu TH; Yu H; Wu L
Int J Cancer; 2024 Mar; 154(5):852-862. PubMed ID: 37860916
[TBL] [Abstract][Full Text] [Related]
3. Blood metabolites and chronic kidney disease: a Mendelian randomization study.
Hou Y; Xiao Z; Zhu Y; Li Y; Liu Q; Wang Z
BMC Med Genomics; 2024 May; 17(1):147. PubMed ID: 38807172
[TBL] [Abstract][Full Text] [Related]
4. Causal association of circulating metabolites with diabetic retinopathy: a bidirectional Mendelian randomization analysis.
Li B; Zhao X; Xie W; Hong Z; Cao Y; Ding Y; Zhang Y
Front Endocrinol (Lausanne); 2024; 15():1359502. PubMed ID: 38800471
[TBL] [Abstract][Full Text] [Related]
5. Causal relationship between resting-state networks and depression: a bidirectional two-sample mendelian randomization study.
Huang D; Wu Y; Yue J; Wang X
BMC Psychiatry; 2024 May; 24(1):402. PubMed ID: 38811927
[TBL] [Abstract][Full Text] [Related]
6. The role of circulating metabolites and gut microbiome in hypertrophic scar: a two-sample Mendelian randomization study.
Cheng X; Cheng B; Jin R; Zheng H; Zhou J; Shan S
Arch Dermatol Res; 2024 Jun; 316(6):315. PubMed ID: 38822918
[TBL] [Abstract][Full Text] [Related]
7. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
8. Linking periodontitis with 20 cancers, emphasis on oropharyngeal cancer: a Mendelian randomization analysis.
Xiong J; Liu H; Li C; Li Y; Feng J
Sci Rep; 2024 May; 14(1):12511. PubMed ID: 38822160
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the causal relationship between plasma and cerebrospinal fluid metabolites and glioblastoma multiforme: a Mendelian Randomization study.
Zhou Z; Leng H
Aging (Albany NY); 2024 May; 16(9):8306-8319. PubMed ID: 38742944
[TBL] [Abstract][Full Text] [Related]
10. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
11. Genetic correlation and causal associations between circulating C-reactive protein levels and lung cancer risk.
Shi J; Wen W; Long J; Xue H; Yang Y; Tao R; Pan W; Shu XO; Cai Q
Cancer Causes Control; 2024 Jun; 35(6):897-906. PubMed ID: 38332239
[TBL] [Abstract][Full Text] [Related]
12. Associations between immune cell phenotypes and lung cancer subtypes: insights from mendelian randomization analysis.
Zheng JM; Lou CX; Huang YL; Song WT; Luo YC; Mo GY; Tan LY; Chen SW; Li BJ
BMC Pulm Med; 2024 May; 24(1):242. PubMed ID: 38755605
[TBL] [Abstract][Full Text] [Related]
13. Causal effects and metabolites mediators between immune cell and risk of breast cancer: a Mendelian randomization study.
Ming R; Wu H; Liu H; Zhan F; Qiu X; Ji M
Front Genet; 2024; 15():1380249. PubMed ID: 38826800
[No Abstract] [Full Text] [Related]
14. Associations between genetically predicted concentrations of circulating inflammatory cytokines and the risk of ten pregnancy-related adverse outcomes: A two-sample Mendelian randomization study.
Chen X; Zhang M; Zhou N; Zhou W; Qi H
Cytokine; 2024 May; 180():156661. PubMed ID: 38795606
[TBL] [Abstract][Full Text] [Related]
15. Causal relationship between genetically determined plasma metabolites and skin cancer: a two-sample Mendelian randomization study.
Shao X; Yu R; Zhao H; Wu J; Wu Q; Shu P
Arch Dermatol Res; 2024 May; 316(6):214. PubMed ID: 38787420
[TBL] [Abstract][Full Text] [Related]
16. Relationship between human serum metabolites and angina pectoris: a Mendelian randomization study.
Xiong J; Liao Y; Yang L; Wei Y; Li D; Zhao Y; Zheng Q; Qi W; Liang F
Postgrad Med J; 2024 Jun; ():. PubMed ID: 38832627
[TBL] [Abstract][Full Text] [Related]
17. Association between human blood metabolome and the risk of gastrointestinal tumors.
Lu J; Feng Y; Guo K; Sun L; Ruan S; Zhang K
PLoS One; 2024; 19(5):e0304574. PubMed ID: 38814898
[TBL] [Abstract][Full Text] [Related]
18. Genotype-based "virtual" metabolomics in a clinical biobank identifies novel metabolite-disease associations.
Bagheri M; Bombin A; Shi M; Murthy VL; Shah R; Mosley JD; Ferguson JF
Res Sq; 2023 Oct; ():. PubMed ID: 37790512
[TBL] [Abstract][Full Text] [Related]
19. Design and quality control of large-scale two-sample Mendelian randomization studies.
Haycock PC; Borges MC; Burrows K; Lemaitre RN; Harrison S; Burgess S; Chang X; Westra J; Khankari NK; Tsilidis KK; Gaunt T; Hemani G; Zheng J; Truong T; O'Mara TA; Spurdle AB; Law MH; Slager SL; Birmann BM; Saberi Hosnijeh F; Mariosa D; Amos CI; Hung RJ; Zheng W; Gunter MJ; Davey Smith G; Relton C; Martin RM;
Int J Epidemiol; 2023 Oct; 52(5):1498-1521. PubMed ID: 38587501
[TBL] [Abstract][Full Text] [Related]
20. Association between human blood metabolites and cerebral cortex architecture: evidence from a Mendelian randomization study.
Jiang Z; Sun Y; Liu S
Front Neurol; 2024; 15():1386844. PubMed ID: 38784905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
